RUSSIAN FOREIGN MINISTRY SAYS UKRAINIAN FORCES ENGAGING IN INTENSE FIGHTING IN EASTERN UKRAINE TO STOP HUMANITARIAN AID TO THE REGION
*ROCHE SAID IN TALKS TO BUY REST OF CHUGAI IN $10 BILLION DEAL
2014-08-15 15:00:59.318 GMT
--ELIZABETH FOURNIER
-0- Aug/15/2014 15:00 GMT
2014-08-15 15:00:59.318 GMT
--ELIZABETH FOURNIER
-0- Aug/15/2014 15:00 GMT
RTRS - UKRAINIAN MILITARY SPOKESMAN SAYS UKRAINE FORCES ENGAGED RUSSIAN ARMOURED COLUMN ON UKRAINIAN SOIL AND "PART OF IT NO LONGER EXISTS"
UKRAINE FORCES ATTACK ARMED CONVOY FROM RUSSIA: LYSENKO
*U.S. AUG. REUTERS/MICHIGAN CONSUMER SENTIMENT INDEX AT 79.2
+------------------------------------------------------------------------------+
EU May Cancel Russia Sanctions If East Ukraine Stabilizes: IFX 2014-08-15 12:42:31.993 GMT
By Torrey Clark Aug. 15 (Bloomberg) -- EU ready to review Russia sanctions if situation in eastern Ukraine clearly stabilizes, although measures were in part imposed over annexation of Crimea, Interfax says, citing interview w/ EU envoy to Russia Vygaudas Usackas. * Sanctions not goal unto themselves * EU doesn’t want to impose more sanctions on Russia * EU hopes Russia will hand over humanitarian aid to Ukraine in compliance w/ intl law * EU hasn’t decided on suing Russia in WTO, ready to defend interests
For Related News and Information: First Word scrolling panel: {FIRST<GO>} First Word newswire: {NH BFW<GO>}
To contact the editor responsible for this story: Torrey Clark at +7-495-771-7709 or tclark8@bloomberg.net
Gapping down
In reaction to disappointing earnings/guidance: ICLD -9%, OPXA -7.8%, PIH -5.7%, PCTY -4.6%, JD -4.4%, JWN -4%, XGTI -3.9%, WB -3.1%, EXTR -1.9%.
Other news: NQ -15.8% ( announces management changes; CFO has resigned from his position for family reasons effective Aug 22, 2014), IDCC -6.7% (co announced it is disappointed with decision by the U.S. International Trade Commission to terminate Investigation No. 337-TA-868), NWBO -5.1% (announced pricing of $17.5 mln offering of convertible notes; convertible at $7.30/share; will fund new manufacturing capacity in Europe), CNAT -3.3% ( filed for a $150 mln mixed securities shelf offering), NEO -2.7% (announced public offering of common stock; size not disclosed), MASI -1.7% (disclosed it received a warning letter from the U.S. FDA regarding compliance with current Good Manufacturing Practices at Masimo's Irvine, CA manufacturing facility.), ZGNX -1.5% (disclosed it received a paragraph IV certification from Actavis (ACT) advising of the filing of an ANDA for a generic version of Zohydro).
Analyst comments: ICPT -2.1% (initiated with a Underperform at FBR Capital; tgt $172 ), KKR -1% (downgraded to Market Perform from Outperform at Wells Fargo), BEBE -0.7% (downgraded to Neutral from Buy at Janney).
In reaction to disappointing earnings/guidance: ICLD -9%, OPXA -7.8%, PIH -5.7%, PCTY -4.6%, JD -4.4%, JWN -4%, XGTI -3.9%, WB -3.1%, EXTR -1.9%.
Other news: NQ -15.8% ( announces management changes; CFO has resigned from his position for family reasons effective Aug 22, 2014), IDCC -6.7% (co announced it is disappointed with decision by the U.S. International Trade Commission to terminate Investigation No. 337-TA-868), NWBO -5.1% (announced pricing of $17.5 mln offering of convertible notes; convertible at $7.30/share; will fund new manufacturing capacity in Europe), CNAT -3.3% ( filed for a $150 mln mixed securities shelf offering), NEO -2.7% (announced public offering of common stock; size not disclosed), MASI -1.7% (disclosed it received a warning letter from the U.S. FDA regarding compliance with current Good Manufacturing Practices at Masimo's Irvine, CA manufacturing facility.), ZGNX -1.5% (disclosed it received a paragraph IV certification from Actavis (ACT) advising of the filing of an ANDA for a generic version of Zohydro).
Analyst comments: ICPT -2.1% (initiated with a Underperform at FBR Capital; tgt $172 ), KKR -1% (downgraded to Market Perform from Outperform at Wells Fargo), BEBE -0.7% (downgraded to Neutral from Buy at Janney).
Gapping up
In reaction to strong earnings/guidance: DQ +10.8%, VRML +10.7%, RIOM +9.5%, CEP +7.9%, LIME +7.6%, YOD +7.5%, SKBI +5.6%, WYY +5.4%, SINA +5.2%, ADSK +4.4%, HTM +4.3%, AMAT +3.8%, XON +3.6%, AGRX +2.7%, ROX +2.7%, CHL +2.7%, UPIP +2.5%, LEI +2%, JCP +2%, KITE +1.7%, MNDL +1.4%, AEG +1.2%, SAND +1%, EL +0.8%, A +0.7%.
M&A news: MNST +20.3% (Monster Beverage and Coca-Cola enter into long-term strategic partnership), KO +1.8% (Monster Beverage and Coca-Cola enter into long-term strategic partnership).
Other news: ACHN +17.5% (achieves 100% sustained virologic response rate from an eight week Phase 2 trial evaluating a ribavirin-free regimen of ACH-3102 and Sofosbuvir for Genotype 1 HCV), CRMD +8.2% (FDA accepted co's pivotal Phase 3 study protocol), FRO +4.3% (cont strength), SODA +3.7% (following MNST / KO ), GCI +2.3% (Icahn disclosed 6.63% active stake in 13D filing; supports split of the company), BHP +2.2% (announced update on portfolio; demerger of a selection of assets is co's preferred option), GLF +2% (to replace QCOR in the S&P SmallCap 600), DNOW +1.9% (new Berkshire Hathaway stake), PARR +1.9% (announced successful completion of common stock rights offering and award of $164 mln contract with Defense Logistics Agency Energy),MNK +1.9% (completes acquisition of Questcor (QCOR)), GILD +1.5% (disclosed favorable ruling in Roche (RHHBY) / Pharmasset case), CHTR +1% (new Berkshire Hathaway stake), EBAY +0.5% (may soon accept bitcoins at its payment unit, according to reports).
Analyst comments: CHL +2.7% (upgraded to Neutral from Underperform at Mizuho), UPL +1.8% (upgraded to Buy from Neutral at UBS ), GSJK +1.5% (upgraded to Overweight from Neutral at JP Morgan), MBI +1.2% (upgraded to Buy from Neutral at BTIG Research ), NXPI +0.8% (initiated with a Buy at Stifel)
In reaction to strong earnings/guidance: DQ +10.8%, VRML +10.7%, RIOM +9.5%, CEP +7.9%, LIME +7.6%, YOD +7.5%, SKBI +5.6%, WYY +5.4%, SINA +5.2%, ADSK +4.4%, HTM +4.3%, AMAT +3.8%, XON +3.6%, AGRX +2.7%, ROX +2.7%, CHL +2.7%, UPIP +2.5%, LEI +2%, JCP +2%, KITE +1.7%, MNDL +1.4%, AEG +1.2%, SAND +1%, EL +0.8%, A +0.7%.
M&A news: MNST +20.3% (Monster Beverage and Coca-Cola enter into long-term strategic partnership), KO +1.8% (Monster Beverage and Coca-Cola enter into long-term strategic partnership).
Other news: ACHN +17.5% (achieves 100% sustained virologic response rate from an eight week Phase 2 trial evaluating a ribavirin-free regimen of ACH-3102 and Sofosbuvir for Genotype 1 HCV), CRMD +8.2% (FDA accepted co's pivotal Phase 3 study protocol), FRO +4.3% (cont strength), SODA +3.7% (following MNST / KO ), GCI +2.3% (Icahn disclosed 6.63% active stake in 13D filing; supports split of the company), BHP +2.2% (announced update on portfolio; demerger of a selection of assets is co's preferred option), GLF +2% (to replace QCOR in the S&P SmallCap 600), DNOW +1.9% (new Berkshire Hathaway stake), PARR +1.9% (announced successful completion of common stock rights offering and award of $164 mln contract with Defense Logistics Agency Energy),MNK +1.9% (completes acquisition of Questcor (QCOR)), GILD +1.5% (disclosed favorable ruling in Roche (RHHBY) / Pharmasset case), CHTR +1% (new Berkshire Hathaway stake), EBAY +0.5% (may soon accept bitcoins at its payment unit, according to reports).
Analyst comments: CHL +2.7% (upgraded to Neutral from Underperform at Mizuho), UPL +1.8% (upgraded to Buy from Neutral at UBS ), GSJK +1.5% (upgraded to Overweight from Neutral at JP Morgan), MBI +1.2% (upgraded to Buy from Neutral at BTIG Research ), NXPI +0.8% (initiated with a Buy at Stifel)
BN 08/15 11:59 *BARCLAYS FINE COULD EXCEED COST OF LIBOR SETTLEMENT WITH U.K.
BN 08/15 11:59 *BARCLAYS FINE SAID TO BE STILL UNDER DISCUSSION WITH REGULATOR
BN 08/15 11:59 *BARCLAYS FINE SAID TO BE STILL UNDER DISCUSSION WITH REGULATOR
*BARCLAYS SAID TO FACE FINE OVER CLIENT ASSET SEGREGATION BREACH
2014-08-15 11:59:48.597 GMT
--EDWARD EVANS
-0- Aug/15/2014 11:59 GMT
2014-08-15 11:59:48.597 GMT
--EDWARD EVANS
-0- Aug/15/2014 11:59 GMT
Early premarket gappers
Gapping up: MNST +21.1%, VRML +10.7%, CRMD +8.2%, LIME +7.6%, ADSK +5.7%, WYY +5.4%, SINA +4.3%, YOD +4.3%, HTM +4.3%, SODA +3.5%, AMAT +3.1%, XON +3.1%, JCP +2.8%, GCI +2.7%, AGRX +2.7%, ROX +2.7%, CHL +2.6%, UPIP +2.5%, CHTR +2.3%, GLF +2%, LEI +2%, PARR +1.9%, MNK +1.9%, MNDL +1.4%, KO +1.3%, FPAY+1.3%, SAND +1%
Gapping down: ICLD -8.6%, OPXA -7.8%, NEO -6.8%, PIH -5.7%, EL -5.6%, NWBO -5.1%, PCTY -4.6%, JD -4.5%, JWN -4%, WB -4%, XGTI -3.9%, CNAT -3.3%, IDCC -3.3%, EXTR -1.9%, ZGNX -1.5%
Gapping down: ICLD -8.6%, OPXA -7.8%, NEO -6.8%, PIH -5.7%, EL -5.6%, NWBO -5.1%, PCTY -4.6%, JD -4.5%, JWN -4%, WB -4%, XGTI -3.9%, CNAT -3.3%, IDCC -3.3%, EXTR -1.9%, ZGNX -1.5%